+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Antibody Drug Conjugates Market 2024-2028

  • PDF Icon

    Report

  • 156 Pages
  • November 2023
  • Region: Global
  • TechNavio
  • ID: 5912576
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The antibody drug conjugates market is forecasted to grow by USD 9.95 bn during 2023-2028, accelerating at a CAGR of 15.06% during the forecast period. The report on the antibody drug conjugates market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer and other diseases, technological advancements in ADC development, and increasing investments in pharmaceutical research and development.

The antibody drug conjugates market is segmented as below:

By Application

  • Breast cancer
  • Blood cancer
  • Others

By Technology

  • Cleavable linker
  • Non-cleavable linker
  • Linkerless

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing adoption and development of targeted therapies as one of the prime reasons driving the antibody drug conjugates market growth during the next few years. Also, advancements in technology and manufacturing processes and increasing demand for personalized medicine in cancer treatment will lead to sizable demand in the market.

The report on the antibody drug conjugates market covers the following areas:

  • Antibody drug conjugates market sizing
  • Antibody drug conjugates market forecast
  • Antibody drug conjugates market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antibody drug conjugates market vendors that include AbbVie Inc., Adcendo ApS, Araris Biotech AG, Astellas Pharma Inc., AstraZeneca Plc, Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., ImmunoGen Inc., Merck KGaA, Mersana Therapeutics Inc., Mythic Therapeutics, Pfizer Inc., Piramal Enterprises Ltd., PPF Group, Regeneron Pharmaceuticals Inc., Seagen Inc., Syngene International Ltd., Takeda Pharmaceutical Co. Ltd., and ADC Therapeutics SA. Also, the antibody drug conjugates market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global antibody drug conjugates market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global antibody drug conjugates market 2018 - 2022 ($ billion)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 Technnology Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Technnology Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Breast cancer - Market size and forecast 2023-2028
Exhibit 34: Chart on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
6.4 Blood cancer - Market size and forecast 2023-2028
Exhibit 38: Chart on Blood cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Blood cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Blood cancer - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Blood cancer - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Exhibit 46: Market opportunity by Application ($ billion)
Exhibit 47: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Technology
7.1 Market segments
Exhibit 48: Chart on Technology - Market share 2023-2028 (%)
Exhibit 49: Data Table on Technology - Market share 2023-2028 (%)
7.2 Comparison by Technology
Exhibit 50: Chart on Comparison by Technology
Exhibit 51: Data Table on Comparison by Technology
7.3 Cleavable linker - Market size and forecast 2023-2028
Exhibit 52: Chart on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Cleavable linker - Year-over-year growth 2023-2028 (%)
7.4 Non-cleavable linker - Market size and forecast 2023-2028
Exhibit 56: Chart on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
7.5 Linkerless - Market size and forecast 2023-2028
Exhibit 60: Chart on Linkerless - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Linkerless - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Linkerless - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Linkerless - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Technology
Exhibit 64: Market opportunity by Technology ($ billion)
Exhibit 65: Data Table on Market opportunity by Technology ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2023-2028 (%)
Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ billion)
Exhibit 108: Data Tables on Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
12.4 ADC Therapeutics SA
Exhibit 119: ADC Therapeutics SA - Overview
Exhibit 120: ADC Therapeutics SA - Product / Service
Exhibit 121: ADC Therapeutics SA - Key offerings
12.5 Astellas Pharma Inc.
Exhibit 122: Astellas Pharma Inc. - Overview
Exhibit 123: Astellas Pharma Inc. - Product / Service
Exhibit 124: Astellas Pharma Inc. - Key news
Exhibit 125: Astellas Pharma Inc. - Key offerings
12.6 AstraZeneca Plc
Exhibit 126: AstraZeneca Plc - Overview
Exhibit 127: AstraZeneca Plc - Product / Service
Exhibit 128: AstraZeneca Plc - Key news
Exhibit 129: AstraZeneca Plc - Key offerings
12.7 Daiichi Sankyo Co. Ltd.
Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Gilead Sciences Inc.
Exhibit 139: Gilead Sciences Inc. - Overview
Exhibit 140: Gilead Sciences Inc. - Product / Service
Exhibit 141: Gilead Sciences Inc. - Key news
Exhibit 142: Gilead Sciences Inc. - Key offerings
12.10 ImmunoGen Inc.
Exhibit 143: ImmunoGen Inc. - Overview
Exhibit 144: ImmunoGen Inc. - Product / Service
Exhibit 145: ImmunoGen Inc. - Key offerings
12.11 Merck KGaA
Exhibit 146: Merck KGaA - Overview
Exhibit 147: Merck KGaA - Business segments
Exhibit 148: Merck KGaA - Key news
Exhibit 149: Merck KGaA - Key offerings
Exhibit 150: Merck KGaA - Segment focus
12.12 Mersana Therapeutics Inc.
Exhibit 151: Mersana Therapeutics Inc. - Overview
Exhibit 152: Mersana Therapeutics Inc. - Product / Service
Exhibit 153: Mersana Therapeutics Inc. - Key offerings
12.13 Pfizer Inc.
Exhibit 154: Pfizer Inc. - Overview
Exhibit 155: Pfizer Inc. - Product / Service
Exhibit 156: Pfizer Inc. - Key news
Exhibit 157: Pfizer Inc. - Key offerings
12.14 Regeneron Pharmaceuticals Inc.
Exhibit 158: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 159: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 160: Regeneron Pharmaceuticals Inc. - Key offerings
12.15 Seagen Inc.
Exhibit 161: Seagen Inc. - Overview
Exhibit 162: Seagen Inc. - Key offerings
12.16 Syngene International Ltd.
Exhibit 163: Syngene International Ltd. - Overview
Exhibit 164: Syngene International Ltd. - Product / Service
Exhibit 165: Syngene International Ltd. - Key offerings
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 168: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 169: Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global antibody drug conjugates market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - Technnology Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Application - Market share 2023-2028 (%)
Exhibits 31: Data Table on Application - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Blood cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Blood cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Blood cancer - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Blood cancer - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Application ($ billion)
Exhibits 47: Data Table on Market opportunity by Application ($ billion)
Exhibits 48: Chart on Technology - Market share 2023-2028 (%)
Exhibits 49: Data Table on Technology - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Technology
Exhibits 51: Data Table on Comparison by Technology
Exhibits 52: Chart on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits 57: Data Table on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits 58: Chart on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Linkerless - Market size and forecast 2023-2028 ($ billion)
Exhibits 61: Data Table on Linkerless - Market size and forecast 2023-2028 ($ billion)
Exhibits 62: Chart on Linkerless - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Linkerless - Year-over-year growth 2023-2028 (%)
Exhibits 64: Market opportunity by Technology ($ billion)
Exhibits 65: Data Table on Market opportunity by Technology ($ billion)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share by geography 2023-2028 (%)
Exhibits 68: Data Table on Market share by geography 2023-2028 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 107: Market opportunity by geography ($ billion)
Exhibits 108: Data Tables on Market opportunity by geography ($ billion)
Exhibits 109: Impact of drivers and challenges in 2023 and 2028
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: AbbVie Inc. - Overview
Exhibits 116: AbbVie Inc. - Product / Service
Exhibits 117: AbbVie Inc. - Key news
Exhibits 118: AbbVie Inc. - Key offerings
Exhibits 119: ADC Therapeutics SA - Overview
Exhibits 120: ADC Therapeutics SA - Product / Service
Exhibits 121: ADC Therapeutics SA - Key offerings
Exhibits 122: Astellas Pharma Inc. - Overview
Exhibits 123: Astellas Pharma Inc. - Product / Service
Exhibits 124: Astellas Pharma Inc. - Key news
Exhibits 125: Astellas Pharma Inc. - Key offerings
Exhibits 126: AstraZeneca Plc - Overview
Exhibits 127: AstraZeneca Plc - Product / Service
Exhibits 128: AstraZeneca Plc - Key news
Exhibits 129: AstraZeneca Plc - Key offerings
Exhibits 130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits 132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 134: F. Hoffmann La Roche Ltd. - Overview
Exhibits 135: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 136: F. Hoffmann La Roche Ltd. - Key news
Exhibits 137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 138: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 139: Gilead Sciences Inc. - Overview
Exhibits 140: Gilead Sciences Inc. - Product / Service
Exhibits 141: Gilead Sciences Inc. - Key news
Exhibits 142: Gilead Sciences Inc. - Key offerings
Exhibits 143: ImmunoGen Inc. - Overview
Exhibits 144: ImmunoGen Inc. - Product / Service
Exhibits 145: ImmunoGen Inc. - Key offerings
Exhibits 146: Merck KGaA - Overview
Exhibits 147: Merck KGaA - Business segments
Exhibits 148: Merck KGaA - Key news
Exhibits 149: Merck KGaA - Key offerings
Exhibits 150: Merck KGaA - Segment focus
Exhibits 151: Mersana Therapeutics Inc. - Overview
Exhibits 152: Mersana Therapeutics Inc. - Product / Service
Exhibits 153: Mersana Therapeutics Inc. - Key offerings
Exhibits 154: Pfizer Inc. - Overview
Exhibits 155: Pfizer Inc. - Product / Service
Exhibits 156: Pfizer Inc. - Key news
Exhibits 157: Pfizer Inc. - Key offerings
Exhibits 158: Regeneron Pharmaceuticals Inc. - Overview
Exhibits 159: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits 160: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits 161: Seagen Inc. - Overview
Exhibits 162: Seagen Inc. - Key offerings
Exhibits 163: Syngene International Ltd. - Overview
Exhibits 164: Syngene International Ltd. - Product / Service
Exhibits 165: Syngene International Ltd. - Key offerings
Exhibits 166: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 167: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 168: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 169: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 170: Inclusions checklist
Exhibits 171: Exclusions checklist
Exhibits 172: Currency conversion rates for US$
Exhibits 173: Research methodology
Exhibits 174: Validation techniques employed for market sizing
Exhibits 175: Information sources
Exhibits 176: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global antibody drug conjugates market: AbbVie Inc., Adcendo ApS, Araris Biotech AG, Astellas Pharma Inc., AstraZeneca Plc, Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., ImmunoGen Inc., Merck KGaA, Mersana Therapeutics Inc., Mythic Therapeutics, Pfizer Inc., Piramal Enterprises Ltd., PPF Group, Regeneron Pharmaceuticals Inc., Seagen Inc., Syngene International Ltd., Takeda Pharmaceutical Co. Ltd., and ADC Therapeutics SA.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing adoption and development of targeted therapies.'

According to the report, one of the major drivers for this market is the growing prevalence of cancer and other diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Adcendo ApS
  • Araris Biotech AG
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • ImmunoGen Inc.
  • Merck KGaA
  • Mersana Therapeutics Inc.
  • Mythic Therapeutics
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • PPF Group
  • Regeneron Pharmaceuticals Inc.
  • Seagen Inc.
  • Syngene International Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • ADC Therapeutics SA

Related Topics

Related Reports

Global Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type (Calicheamicin, MMAE), Target (HER2, CD30, CD22), Disease, and Region - Forecast to 2028 - Product Image

Global Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type (Calicheamicin, MMAE), Target (HER2, CD30, CD22), Disease, and Region - Forecast to 2028

  • Report
  • 273 Pages
  • Global
From
Global Antibody Drug Conjugates Contract Manufacturing Market by Linker (Cleavable, Non-cleavable), Condition (Breast Cancer, Lymphoma, Myeloma), End Use - Forecast 2024-2030 - Product Image

Global Antibody Drug Conjugates Contract Manufacturing Market by Linker (Cleavable, Non-cleavable), Condition (Breast Cancer, Lymphoma, Myeloma), End Use - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From
Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer), By Technology ({Type-Cleavable, Non-cleavable}), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer), By Technology ({Type-Cleavable, Non-cleavable}), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 135 Pages
  • Global
From
Global Antibody Drug Conjugate Market by Mechanism of Action (CD30 Antibodies, ErbB2 Antibodies), Drugs (Adcetris, Blenrep, Enhertu), Technology, Indication, End User - Forecast 2023-2030 - Product Image

Global Antibody Drug Conjugate Market by Mechanism of Action (CD30 Antibodies, ErbB2 Antibodies), Drugs (Adcetris, Blenrep, Enhertu), Technology, Indication, End User - Forecast 2023-2030

  • Report
  • 181 Pages
  • Global
From
Global Antibody Drug Conjugate (ADC) Growth Opportunities, Forecast to 2028 - Product Image

Global Antibody Drug Conjugate (ADC) Growth Opportunities, Forecast to 2028

  • Report
  • 55 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.